Yucheng Lu

776 total citations
46 papers, 600 citations indexed

About

Yucheng Lu is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Yucheng Lu has authored 46 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Neurology and 7 papers in Oncology. Recurrent topics in Yucheng Lu's work include Microtubule and mitosis dynamics (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Cancer-related Molecular Pathways (4 papers). Yucheng Lu is often cited by papers focused on Microtubule and mitosis dynamics (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Cancer-related Molecular Pathways (4 papers). Yucheng Lu collaborates with scholars based in China, United Kingdom and Hong Kong. Yucheng Lu's co-authors include Pu Wang, Shao Chin Lee, Jixu Yu, Hao Wang, Shimeng Zhang, Liangjun Jiang, Quanping Su, Lan Wang, Fengyuan Che and Na Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Yucheng Lu

41 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yucheng Lu China 16 300 81 77 68 66 46 600
Yuanyuan Xie China 14 221 0.7× 72 0.9× 57 0.7× 101 1.5× 110 1.7× 49 656
Ruifeng Lu China 13 449 1.5× 136 1.7× 77 1.0× 95 1.4× 39 0.6× 19 740
Yota Tatara Japan 13 457 1.5× 52 0.6× 50 0.6× 92 1.4× 38 0.6× 44 805
Özlem Yıldırım Türkiye 17 594 2.0× 62 0.8× 106 1.4× 48 0.7× 54 0.8× 62 1.1k
Shuai Huang China 15 378 1.3× 166 2.0× 42 0.5× 32 0.5× 80 1.2× 40 669
Aijing Sun China 13 387 1.3× 78 1.0× 24 0.3× 75 1.1× 88 1.3× 34 613
Shuai Yuan China 13 368 1.2× 166 2.0× 44 0.6× 41 0.6× 56 0.8× 29 597
Weifeng Mao China 18 512 1.7× 154 1.9× 37 0.5× 176 2.6× 63 1.0× 42 937
Zhiwei Feng China 15 242 0.8× 84 1.0× 22 0.3× 94 1.4× 31 0.5× 29 531
Ning An China 17 352 1.2× 136 1.7× 23 0.3× 111 1.6× 81 1.2× 66 761

Countries citing papers authored by Yucheng Lu

Since Specialization
Citations

This map shows the geographic impact of Yucheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yucheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yucheng Lu more than expected).

Fields of papers citing papers by Yucheng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yucheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yucheng Lu. The network helps show where Yucheng Lu may publish in the future.

Co-authorship network of co-authors of Yucheng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yucheng Lu. A scholar is included among the top collaborators of Yucheng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yucheng Lu. Yucheng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Yanyan, Xueying Wu, Yucheng Lu, et al.. (2025). Low miR-224–5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4. Drug Resistance Updates. 79. 101211–101211. 5 indexed citations
2.
Lu, Yucheng, Ying Huang, Cuiqing Zhu, et al.. (2025). Cancer brain metastasis: molecular mechanisms and therapeutic strategies. Molecular Biomedicine. 6(1). 12–12. 3 indexed citations
3.
Lu, Yucheng, et al.. (2025). Structural isomerisation affects the antitubercular activity of adamantyl-isoxyl adducts. Journal of Enzyme Inhibition and Medicinal Chemistry. 40(1). 2502600–2502600.
4.
Tu, Jian, Liang Peng, Rui Fang, et al.. (2024). MRI-based radiomics virtual biopsy for BCL6 in primary central nervous system lymphoma. Clinical Radiology. 80. 106746–106746. 2 indexed citations
5.
Xu, Linghui, et al.. (2024). MRI-based radiomics signatures for preoperative prediction of Ki-67 index in primary central nervous system lymphoma. European Journal of Radiology. 178. 111603–111603. 2 indexed citations
6.
Lu, Yucheng, et al.. (2021). Association between diabetes and acute lymphocytic leukemia, acute myeloid leukemia, non-Hopkin lymphoma, and multiple myeloma. International Journal of Diabetes in Developing Countries. 42(4). 694–702. 2 indexed citations
7.
Shi, Ke, Jin Z. Zhang, Liang Yang, et al.. (2021). Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma. BMC Cancer. 21(1). 1196–1196. 18 indexed citations
8.
Brown, Alistair K., et al.. (2020). Identification of Substituted Amino Acid Hydrazides as Novel Anti-Tubercular Agents, Using a Scaffold Hopping Approach. Molecules. 25(10). 2387–2387. 5 indexed citations
9.
You, Cuiping, Rui Tao, Quanping Su, et al.. (2019). Mitochondrial DNA analyses found five novel mutations in idiopathic epilepsy patients. SHILAP Revista de lepidopterología. 4(2). 2387–2391. 1 indexed citations
10.
Wang, Jinfeng, Fengyuan Che, Jinling Zhang, et al.. (2019). Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma. World Neurosurgery. 125. e1217–e1225. 15 indexed citations
11.
Lu, Yucheng, et al.. (2019). Study on Extraction of Dietary Fiber from Potato Peel by Acid-base Chemical Method. IOP Conference Series Earth and Environmental Science. 267(5). 52028–52028. 6 indexed citations
12.
Lin, Hung‐Ju, Jenn‐Ren Hsiao, Jeffrey S. Chang, et al.. (2019). Resected specimen size: A reliable predictor of severe Frey syndrome after parotidectomy. Head & Neck. 41(7). 2285–2290. 4 indexed citations
13.
Wang, Pu, et al.. (2018). Advanced Glycation End Products Increase MDM2 Expression via Transcription Factor KLF5. Journal of Diabetes Research. 2018. 1–12. 14 indexed citations
14.
Jia, Lixin, Wenmei Zhang, Taotao Li, et al.. (2017). ER stress dependent microparticles derived from smooth muscle cells promote endothelial dysfunction during thoracic aortic aneurysm and dissection. Clinical Science. 131(12). 1287–1299. 76 indexed citations
15.
Che, Fengyuan, Guangying Wang, Jixu Yu, et al.. (2017). Effects of epigallocatechin-3-gallate on iron metabolism in spinal cord motor neurons. Molecular Medicine Reports. 16(3). 3010–3014. 9 indexed citations
16.
Su, Quanping, et al.. (2017). Effects of mutant TDP-43 on the Nrf2/ARE pathway and protein expression of MafK and JDP2 in NSC-34 cells. Genetics and Molecular Research. 16(2). 22 indexed citations
17.
Dong, Mengyi, et al.. (2017). Antioxidant activity of queen bee larvae processed by enzymatic hydrolysis. Journal of Food Processing and Preservation. 42(2). e13461–e13461. 15 indexed citations
18.
Lu, Yucheng, et al.. (2015). Enzymatic extraction of squid viscera oil and its fatty acid analysis.. Zhongguo youzhi. 40(3). 1–5. 2 indexed citations
19.
Wang, Fumin, Yucheng Lu, Quanping Su, et al.. (2014). Effect of the human SOD1-G93A gene on the Nrf2/ARE signaling pathway in NSC-34 cells. Molecular Medicine Reports. 9(6). 2453–2458. 23 indexed citations
20.
Lu, Yucheng, Xueyuan Heng, Jixu Yu, et al.. (2014). miR-137 regulates the migration of human umbilical vein endothelial cells by targeting ephrin-type A receptor 7. Molecular Medicine Reports. 10(3). 1475–1480. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026